Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-19-001279
Filing Date
2019-02-22
Accepted
2019-02-22 16:38:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 STEMLINE THERAPEUTICS INC p19-0689sc13g.htm SC 13G 105802
  Complete submission text file 0000902664-19-001279.txt   107406
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 (617) 867-2800
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) CIK: 0001165408 (see all company filings)

EIN.: 043574590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Subject) CIK: 0001264587 (see all company filings)

EIN.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87209 | Film No.: 19626215
SIC: 2834 Pharmaceutical Preparations